Truist Financial’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $243K | Buy |
3,309
+631
| +24% | +$46.3K | ﹤0.01% | 2295 |
|
|
2025
Q1 | $306K | Buy |
+2,678
| New | +$306K | ﹤0.01% | 2117 |
|
|
2024
Q2 | – | Sell |
-9,246
| Closed | -$233K | – | 2651 |
|
|
2024
Q1 | $233K | Sell |
9,246
-5,507
| -37% | -$139K | ﹤0.01% | 2406 |
|
|
2023
Q4 | $479K | Sell |
14,753
-3,776
| -20% | -$123K | ﹤0.01% | 1997 |
|
|
2023
Q3 | $505K | Buy |
18,529
+8,711
| +89% | +$237K | ﹤0.01% | 1917 |
|
|
2023
Q2 | $218K | Sell |
9,818
-21,580
| -69% | -$480K | ﹤0.01% | 2398 |
|
|
2023
Q1 | $680K | Buy |
31,398
+8,861
| +39% | +$192K | ﹤0.01% | 1776 |
|
|
2022
Q4 | $458K | Buy |
+22,537
| New | +$458K | ﹤0.01% | 2014 |
|
|
2022
Q3 | – | Sell |
-15,295
| Closed | -$364K | – | 2529 |
|
|
2022
Q2 | $364K | Hold |
15,295
| – | – | ﹤0.01% | 2090 |
|
|
2022
Q1 | $344K | Hold |
15,295
| – | – | ﹤0.01% | 2217 |
|
|
2021
Q4 | $303K | Buy |
+15,295
| New | +$303K | ﹤0.01% | 2316 |
|
|
2020
Q4 | – | Sell |
-28,080
| Closed | -$489K | – | 2532 |
|
|
2020
Q3 | $489K | Sell |
28,080
-4,540
| -14% | -$79.1K | ﹤0.01% | 1728 |
|
|
2020
Q2 | $549K | Sell |
32,620
-3,829
| -11% | -$64.4K | ﹤0.01% | 1561 |
|
|
2020
Q1 | $433K | Sell |
36,449
-4,133
| -10% | -$49.1K | ﹤0.01% | 1620 |
|
|
2019
Q4 | $491K | Buy |
+40,582
| New | +$491K | ﹤0.01% | 1862 |
|